Top Glove Corporation Bhd. (TGLVY) Financials
TGLVY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| May 31, 2026 | 1.7 billion | 439.8 million |
| Feb. 28, 2026 | 1.6 billion | 399.3 million |
| Nov. 30, 2025 | 1.5 billion | 374.9 million |
| Aug. 31, 2025 | 1.5 billion | 352.9 million |
TGLVY Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| May 31, 2026 | 20.5 million | ? |
| Feb. 28, 2026 | 3.3 million | ? |
| Nov. 30, 2025 | 8.3 million | ? |
| Aug. 31, 2025 | 35.8 million | ? |
TGLVY Net Income
| Date | Net Income |
|---|---|
| May 31, 2026 | 25.3 million |
| Feb. 28, 2026 | 7.7 million |
| Nov. 30, 2025 | 10.9 million |
| Aug. 31, 2025 | 9.1 million |
TGLVY Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| May 31, 2026 | 194.1 million | 201.1 million | 6.3 million |
| Feb. 28, 2026 | 175.8 million | 205.1 million | 6.7 million |
| Nov. 30, 2025 | 172.5 million | 193.2 million | 6.5 million |
| Aug. 31, 2025 | 132.7 million | 189.0 million | 5.2 million |
TGLVY Shares Outstanding
TGLVY Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| May 31, 2026 | 6.5 million | - | - | - |
| Feb. 28, 2026 | 11.0 million | - | - | - |
| Nov. 30, 2025 | 1.2 million | - | - | - |
| Aug. 31, 2025 | 6.5 million | - | - | - |
TGLVY Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| May 31, 2026 | 275.8 million | - |
| Feb. 28, 2026 | 258.3 million | 237.4 million |
| Nov. 30, 2025 | 213.8 million | 200.7 million |
| Aug. 31, 2025 | 210.6 million | 202.7 million |
TGLVY
Price: $0.79
Dividend Yield: 0.67%
Forward Dividend Yield: 1.85%
Dividend Per Share: 0.01 USD
Earnings Per Share: 0.02 USD
P/E Ratio: 28.90
Exchange: PNK
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: Malaysia
Volume: 2100
Ebitda: 118.5 millionMarket Capitalization: 1.4 billion
Average Dividend Frequency: 1
Years Paying Dividends: 2